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 Abstract: The aim of the study was to evaluate chromium diffusion in sexual organs and sexual 
accessory glands as one of the first marker of the possible chromium action on reproductive system. 
Subcutaneous administration of potassium dichromate 2% in dosis of 0.5 x LOAEL, LOAEL and 3 x LOAEL to 
male rats pointed out: increase of blood chromium level direct correlated to doses level and duration of 
administration; accumulation of chromium in male genital organs, sexual accessory glands in the succession: 




 Chromium is a transition element which is an essential element for animals but a toxic 
one too. It was reveled that chromium causes skin and respiratory irritation and lung cancer, 
oxidative stress. There are a few data concerning the consequences of exposure to chromium 
on the markers of chromium reproductive toxicity. 
 The determination of a possible reproductive toxicant in tissues and organs, including 
sexual one, is precized in the Guideline for reproductive toxicity test (3). 
 The aim of the study was to evaluate chromium diffusion in sexual organs and sexual 
accessory glands as one of the first marker of the possible chromium action on reproductive 
system.  
 
MATERIAL AND METHODS 
 
 The study was carried out on 28 white Wistar male rats divided in 4 groups (three 
experimental E and one control C). Potassium dichromate solution 2% was administered s.c., 
ones/day, at the level of: 0.5 x LOAEL (E1), LOAEL (for reproductive toxicity – 12,9mg/kg 
bw/day) (E2) and 3 x LOAEL (E3) during 7 days.  
 Blood samples were drown at 24 h for chromium determination and blood, liver, 
kidneys, spleen, brain, testis, epididymis, seminal vesicles, prostate and bulbo-urethral glands 
at 7 days of administration. 
 Chromium was determined by atomic absorption spectrophotometer AA-6650 
Shimadzu with graphite furnance. 
 The results were statistically analyzed by ANOVA method and Student test. 
 
 
RESULTS AND DISCUSSIONS 
 
Results are summarized in tables 1, 2, 3 and 4. 
 362 
 
Table 1 Blood chromium concentration (µg/g) at 24h after administration 
Group x ± Sx DS Confidence interval 95% 
C 0.69 ± 0.05 0.16 0.21 
E1 2.68 ± 0.06 ** 0.17 0.21 
E2 3.61 ± 0.04 ** 0.12 0.21 
E3 7.68 ± 0.18 ** 0.55 0.21 
Differences E/C: **: p<0.01      
 
Table 2 Blood chromium concentration (µg/g) at 7 days of administration 
Group x ± Sx DS Confidence interval 95% 
C 1.03 ± 0.07 0.2 0.36 
E1 5.21 ± 0.24 ** 0.71 0.36 
E2 7.43 ± 0.25 ** 0.76 0.36 
E3 # - - - 
Differences E/C: **: p<0.01                                                                               # - died in 48h          
 
Subcutaneous potassium dichromate (Cr6+) administration determined significant 
(p<0,01) increase of blood chromium level comparatively to C group at 24h after 
administration (E1/C: +288.4%, E2/C: +428.18%, E3/C: +1013.04%) and at 7 days of 
administration (E1/C: +405.82%, E2/C: +621.35%), directly correlated to level of 
administration (at 24h: E2/E1: +34.7%, p<0.05; E3/E1: +186.56%, p<0.01; E3/E2: +112.72%, 
p<0.01; at 7 days: E2/E1: +42.61%, p<0.01).  
 
Table 3 Chromium concentration (µg/g) in male sexual organs and sexual accessory glands 
Specification x ± Sx DS Confidence interval 95% 
C 0.29±0.02 0.07 0.05 
E1 1.1±0.05 ** 0.16 0.12 




E3 # - - - 
C 0.13±0.01 0.01 0.01 
E1 0.35±0.01 ** 0.02 0.02 




E3 # - - - 
C 0.24±0.01 0.02 0.03 
E1 0.68±0.02 ** 0.06 0.03 
E2 1.05±0.02 ** 0.05 0.03 
 
Seminal vesicles 
E3 # - - - 
C 0.18±0.01 0.03 0.02 
E1 0.42±0.01 ** 0.03 0.02 




E3 # - - - 
C 0.22±0.01 0.04 0.03 
E1 0.56±0.02 ** 0.07 0.03 




E3 # - - - 
Differences E/C: **: p<0.01                                                                                         # - died in 48h          
Potassium dichromate administration for 7 days has had as consequences the significant 
(p<0.01) increase of chromium concentration in male genital organs and sexual accessory 
glands comparatively to C group (testis: E1/C: +279.3%, E2/C: +924.13%; epididymis: E1/C: 
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+169.23%, E2/C: +453.84%; seminal vesicles: E1/C: +183.33%, E2/C: +337.5%; prostate: 
E1/C: +133.33%, E2/C: +244.44%; bulbo-urethral glands: E1/C: +154.54%, E2/C: +336.36%). 
Chromium concentration in genital organs and sexual accessory glands increased direct 
correlated to administrated level (p<0.01) (testis: E2/E1: +170%; epididymis: E2/E1: 
+105.71%; seminal vesicles: E2/E1: +54.41%; prostates: E2/E1: +47.61%; bulbo-urethral 
glands: E2/E1: +71.42%). 
 
Table 4 Chromium concentration (µg/g) in male sexual organs and sexual accessory glands 
Specification x ± Sx DS Confidence interval 95% 
C 3.87±0.29 0.86 1.6 
E1 30.24±1.47 ** 4.42 1.6 




E3 # - - - 
C 4.83±0.13 0.38 1.51 
E1 50.01±0.37 ** 1.11 1.51 




E3 # - - - 
C 3.08±0.09 0.28 0.57 
E1 15.13±0.47 ** 1.41 0.57 




E3 # - - - 
C 0.43±0.01 0.03 0.04 
E1 0.99±0.01 ** 0.03 0.04 




E3 # - - - 
Differences E/C: **: p<0.01                                                                                         # - died in 48h          
 
Chromium concentration in other organs increased significant (p<0.01) comparatively to 
C group (liver: E1/C: +681.39%, E2/C: +1126.87%; kidneys: E1/C: +935.4%, E2/C: 
+1443.68%; spleen: E1/C: +391.23%, E2/C: +689.61%; brain: E1/C: +130.23%, E2/C: 
+234.88%). 
Chromium concentrations in organs increased in direct correlation to exposure level 
(p<0.01): liver: E2/E1: +57.01%, kidneys: E2/E1: +49.09%, spleen: E2/E1: +58.85%, brain: 
E2/E1: +45.45%. 
Chromium diffusion and accumulation in testis was described by authors (1, 2, 4). 
Chromium accumulation in liver, kidney, bone and spleen was emphasized by Hopkins, 1965 




 Subcutaneous administration of potassium dichromate 2% in dosis of 0.5 x LOAEL, 
LOAEL and 3 x LOAEL to male rats pointed out: 
• increase of blood chromium level direct correlated to doses level and duration of 
administration;  
• accumulation of chromium in male genital organs, sexual accessory glands in the 
succession: testes, seminal vesicles, bulbo-urethral glands, prostate, epididymis and in 
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